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Following publication of this article, the authors became
aware of an error regarding the effect alleles for genetic
variants associated with circulating interleukin 6 (IL-6). The
effect alleles for genetic variants associated with circulating
interleukin 6 (IL-6) were misaligned due to an error pro-
pagated from a previous publication in which the minor
allele of the IL6R variant rs7529229 was incorrectly
labelled as the T allele [1].
Based on this error, effect alleles for three variants in the
IL6R gene region require correction, which leads to changes
in Supplementary Table 6, and Mendelian randomization
estimates for IL-6.
The changes made to the original article are
detailed below:
1. In the “Abstract”:
“The odds ratio for depression per standard deviation
increase in genetically-predicted triglycerides was 1.18 (95%
CI 1.09–1.27; p= 2 × 10−5); per unit increase in genetically-
predicted log-transformed IL-6 was 0.74 (95% CI 0.62–0.89;
p= 0.0012); and per unit increase in genetically-predicted log-
transformed CRP was 1.18 (95% CI 1.07–1.29; p= 0.0009).”
was changed to:
“The odds ratio for depression per standard deviation
increase in genetically-predicted triglycerides was 1.18
(95% CI 1.09–1.27; p= 2 × 10−5); per unit increase in
genetically-predicted log-transformed IL-6 was 1.35 (95%
CI 1.12–1.62; p= 0.0012); and per unit increase in
genetically-predicted log-transformed CRP was 1.18 (95%
CI 1.07–1.29; p= 0.0009).”
2. In the “Results” section, under the heading “Mende-
lian randomization analyses”:
“For the inflammatory biomarkers (Table 3), there was
an evidence for causal effects of IL-6 and CRP, with an
odds ratio of 0.74 (95% CI: 0.62–0.89, p= 0.0012) per unit
increase in genetically-predicted values of log-transformed
IL-6 (Fig. 1b)…”
was changed to:
“For the inflammatory biomarkers (Table 3), there was
evidence for causal effects of IL-6 and CRP, with an odds
ratio of 1.35 (95% CI 1.12–1.62; p= 0.0012) per unit
increase in genetically-predicted values of log-transformed
IL-6 (Fig. 1b)…”
Additionally, in this section:
“Although these results appear to be in different direc-
tions, variants in the IL6R gene region affect cellular
binding of interleukin-6 receptor (IL-6R). Increased circu-
lating concentrations of IL-6 do not represent increased
production of IL-6, but rather reduced cellular binding [37].
Hence for both inflammatory markers, increased levels of
the inflammatory marker lead to greater risk of depression.”
was changed to:
“The alleles associated with increased IL-6 levels are
also associated with decreased CRP levels. This provides
a discrepancy in the interpretation of results based on
variants in the IL6R and CRP gene regions: variants in
the CRP gene region associated with increased
CRP levels were associated with increased risk of
depression, whereas variants in the IL6R gene region
associated with increased circulating IL-6 levels but
decreased IL-6 activity and decreased CRP levels were
associated with increased risk of depression. Further
investigation is needed to understand this discrepancy,
which could be linked to divergent effects of IL-6 clas-
sical and trans signalling on depression risk, and/or CRP-
















3. In Table 3, in the row IL-6, the odds ratio (95% CI)
was changed from “0.74 (0.62–0.89)” to “1.35
(1.12–1.62)”.
4. Figure 1b has been corrected. In the corrected figure,
for each of the three variants in the IL6R gene region
considered, the allele associated with increased circulating
IL-6 concentrations is also associated with increased risk
of depression. The correct Mendelian randomization
estimate based on these genetic variants is an odds ratio of
1.35 (95% confidence interval 1.12–1.62, p= 0.0012) for
depression per unit increase in log-transformed circulating
levels of IL-6.
The original, incorrect version of Fig. 1 is displayed
below for reference.
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5. The supplementary file has been replaced. The chan-
ges made to this file are as follows:
In supplementary Table 6, the effect alleles for IL-6
biomarkers were corrected from “T, T, T”, to “C, C, G”.
In Supplementary Table 9, the odds ratio (95% CI) for
IL-6 was changed from “0.74 (0.58 to 0.93)”, to “1.36 (1.07
to 1.72)”.
In Supplementary Table 10, the odds ratio (95% CI) for IL-
6 was changed from “0.76 (0.58–1.00)”, to “1.32 (1.00–1.74)”.
The overall finding from the manuscript abstract that “IL-6,
CRP and triglycerides, are likely to be causally linked with
depression, so could be targets for treatment and prevention of
depression” remains true, even though the direction of estimate
for IL-6 was incorrect. The p-values for the associations of
genetically-predicted IL-6 with depression remain unchanged.
This has been corrected in both the PDF and HTML
versions of the article.
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